Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Wells Fargo & Company from $275.00 to $287.00 in a research note released on Friday morning,Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued reports about the company. Bank of America […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Wells Fargo & Company from $275.00 to $287.00 in a research note released on Friday morning,Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued reports about the company. Bank of America […]
